EGFR and interstitial lung disease: A study in a population with a high co-incidence of pulmonary disease proposed that the mechanism for developing epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-induced ILD was most likely related to a decrease in alveolar regeneration (23).